全身麻醉下成人和儿童的频谱熵监测
Spectral entropy monitoring for adults and children undergoing general anaesthesia.
作者信息
Chhabra Anjolie, Subramaniam Rajeshwari, Srivastava Anurag, Prabhakar Hemanshu, Kalaivani Mani, Paranjape Saloni
机构信息
Department of Anaesthesiology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India, 110029.
出版信息
Cochrane Database Syst Rev. 2016 Mar 14;3(3):CD010135. doi: 10.1002/14651858.CD010135.pub2.
BACKGROUND
Anaesthetic drugs during general anaesthesia are titrated according to sympathetic or somatic responses to surgical stimuli. It is now possible to measure depth of anaesthesia using electroencephalography (EEG). Entropy, an EEG-based monitor can be used to assess the depth of anaesthesia using a strip of electrodes applied to the forehead, and this can guide intraoperative anaesthetic drug administration.
OBJECTIVES
The primary objective of this review was to assess the effectiveness of entropy monitoring in facilitating faster recovery from general anaesthesia. We also wanted to assess mortality at 24 hours, 30 days, and one year following general anaesthesia with entropy monitoring.The secondary objectives were to assess the effectiveness of the entropy monitor in: preventing postoperative recall of intraoperative events (awareness) following general anaesthesia; reducing the amount of anaesthetic drugs used; reducing cost of the anaesthetic as well as in reducing time to readiness to leave the postanaesthesia care unit (PACU).
SEARCH METHODS
We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2014, Issue 10), MEDLINE via Ovid SP (1990 to September 2014) and EMBASE via Ovid SP (1990 to September 2014). We reran the search in CENTRAL, MEDLINE via Ovid SP and EMBASE via Ovid SP in January 2016. We added one potential new study of interest to the list of 'Studies awaiting Classification' and we will incorporate this study into the formal review findings during the review update.
SELECTION CRITERIA
We included randomized controlled trials (RCTs) conducted in adults and children (aged greater than two years of age), where in one arm entropy monitoring was used for titrating anaesthesia, and in the other standard practice (increase in heart rate, mean arterial pressure, lacrimation, movement in response to noxious surgical stimuli) was used for titrating anaesthetic drug administration. We also included trials with an additional third arm, wherein another EEG monitor, the Bispectral index (BIS) monitor was used to assess anaesthetic depth.
DATA COLLECTION AND ANALYSIS
We used standard methodological procedures expected by Cochrane. Two review authors independently extracted details of trial methodology and outcome data from trials considered eligible for inclusion. All analyses were made on an intention-to-treat basis. We used a random-effect model where there was heterogeneity. For assessments of the overall quality of evidence for each outcome that included pooled data from RCTs, we downgraded evidence from 'high quality' by one level for serious (or by two for very serious) study limitations (risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect or potential publication bias).
MAIN RESULTS
We included 11 RCTs (962 participants). Eight RCTs (762 participants) were carried out on adults (18 to 80 years of age), two (128 participants) involved children (two to 16 years) and one RCT (72 participants) included patients aged 60 to 75 years. Of the 11 included studies, we judged three to be at low risk of bias, and the remaining eight RCTs at unclear or high risk of bias.Six RCTs (383 participants) estimated the primary outcome, time to awakening after stopping general anaesthesia, which was reduced in the entropy as compared to the standard practice group (mean difference (MD) -5.42 minutes, 95% confidence interval (CI) -8.77 to -2.08; moderate quality of evidence). We noted heterogeneity for this outcome; on performing subgroup analysis this was found to be due to studies that included participants undergoing major, long duration surgeries (off-pump coronary artery bypass grafting, major urological surgery). The MD for time to awakening with four studies on ambulatory procedures was -3.20 minutes (95% CI -3.94 to -2.45). No trial reported the second primary outcome, mortality at 24 hours, 30 days, and one year with the use of entropy monitoring.Eight trials (797 participants) compared the secondary outcome, postoperative recall of intraoperative events (awareness) in the entropy and standard practice groups. Awareness was reported by only one patient in the standard practice group, making meaningful estimation of benefit of entropy monitoring difficult; moderate quality of evidence.All 11 RCTs compared the amount of anaesthetic agent used between the entropy and standard practice groups. Six RCTs compared the amount of propofol, four compared the amount of sevoflurane and one the amount of isoflurane used between the groups. Analysis of three studies (166 participants) revealed that the MD of propofol consumption between the entropy group and control group was -11.56 mcg/kg/min (95% CI -24.05 to 0.92); low quality of evidence. Analysis of another two studies (156 participants) showed that the MD in sevoflurane consumption in the entropy group compared to the control group was -3.42 mL (95% CI -6.49 to -0.35); moderate quality of evidence.No trial reported on the secondary outcome of the cost of general anaesthesia.Three trials (170 participants) estimated MD in time to readiness to leave the PACU of the entropy group as compared to the control group (MD -5.94 minutes, 95% CI -16.08 to 4.20; low quality of evidence). Heterogeneity was noted, which was due to the difference in anaesthetic technique (propofol-based general anaesthesia) in one study. The remaining two studies had used volatile-based general anaesthesia. The MD in time to readiness to leave the PACU was -4.17 minutes (95% CI -6.84 to -1.51) with these two studies.
AUTHORS' CONCLUSIONS: The evidence as regards time to awakening, recall of intraoperative awareness and reduction in inhalational anaesthetic agent use was of moderate quality. The quality of evidence of as regards reduction in intravenous anaesthetic agent (propofol) use, as well as time to readiness to leave the PACU was found to be of low quality. As the data are limited, further studies consisting of more participants will be required for ascertaining benefits of entropy monitoring.Further studies are needed to assess the effect of entropy monitoring on focal issues such as short-term and long-term mortality, as well as cost of general anaesthesia.
背景
全身麻醉期间,麻醉药物根据对手术刺激的交感神经或躯体反应进行滴定。现在可以使用脑电图(EEG)来测量麻醉深度。熵,一种基于脑电图的监测仪,可通过应用于前额的一条电极带用于评估麻醉深度,这可以指导术中麻醉药物的给药。
目的
本综述的主要目的是评估熵监测在促进全身麻醉后更快恢复方面的有效性。我们还想评估熵监测下全身麻醉后24小时、30天和1年的死亡率。次要目的是评估熵监测仪在以下方面的有效性:预防全身麻醉后对术中事件(知晓)的术后回忆;减少麻醉药物的使用量;降低麻醉成本以及缩短离开麻醉后护理单元(PACU)的准备时间。
检索方法
我们检索了Cochrane对照试验中心注册库(CENTRAL;2014年第10期)通过Ovid SP检索的MEDLINE(1990年至2014年9月)以及通过Ovid SP检索的EMBASE(1990年至2014年9月)。我们于2016年1月在CENTRAL、通过Ovid SP检索的MEDLINE和通过Ovid SP检索的EMBASE中重新进行了检索。我们将一项潜在的新的感兴趣的研究添加到“待分类研究”列表中,并将在综述更新期间将该研究纳入正式的综述结果中。
选择标准
我们纳入了在成人和儿童(年龄大于2岁)中进行的随机对照试验(RCT),其中一组使用熵监测来滴定麻醉,另一组使用标准方法(心率、平均动脉压、流泪、对有害手术刺激的反应性运动增加)来滴定麻醉药物给药。我们还纳入了另外有第三组的试验,其中使用另一种脑电图监测仪,双谱指数(BIS)监测仪来评估麻醉深度。
数据收集与分析
我们采用了Cochrane预期的标准方法程序。两位综述作者独立从被认为符合纳入条件的试验中提取试验方法和结局数据的详细信息。所有分析均基于意向性分析。在存在异质性的情况下,我们使用随机效应模型。对于包括来自RCT的汇总数据的每个结局的证据总体质量评估,我们因严重(或非常严重时降低两级)研究局限性(偏倚风险、证据的间接性、严重不一致性、效应的不精确性或潜在的发表偏倚)将证据从“高质量”下调一级。
主要结果
我们纳入了11项RCT(962名参与者)。8项RCT(762名参与者)在成人(18至80岁)中进行,2项(128名参与者)涉及儿童(2至16岁),1项RCT(72名参与者)纳入了60至75岁的患者。在纳入研究的11项中,我们判断3项偏倚风险较低,其余8项RCT偏倚风险不明确或较高。6项RCT(383名参与者)估计了主要结局,即停止全身麻醉后的苏醒时间,与标准方法组相比,熵组的苏醒时间缩短(平均差(MD)-5.42分钟,95%置信区间(CI)-8.77至-2.08;证据质量中等)。我们注意到该结局存在异质性;进行亚组分析时发现这是由于纳入了接受大型、长时间手术(非体外循环冠状动脉搭桥术、大型泌尿外科手术)参与者的研究。4项关于门诊手术的研究中苏醒时间的MD为-3.20分钟(95%CI-3.94至-2.45)。没有试验报告第二个主要结局,即使用熵监测时24小时、30天和1年的死亡率。8项试验(797名参与者)比较了次要结局,即熵组和标准方法组中术后对术中事件(知晓)的回忆。标准方法组中只有1名患者报告有知晓情况,这使得难以对熵监测的益处进行有意义的评估;证据质量中等。所有11项RCT比较了熵组和标准方法组之间使用的麻醉剂用量。6项RCT比较了丙泊酚用量,4项比较了七氟醚用量,1项比较了异氟醚用量。对3项研究(166名参与者)的分析显示,熵组与对照组之间丙泊酚消耗量的MD为-11.56 mcg/kg/min(95%CI-24.05至0.92);证据质量低。对另外2项研究(156名参与者)的分析表明,与对照组相比,熵组中七氟醚消耗量的MD为-3.42 mL(95%CI-6.49至-0.35);证据质量中等。没有试验报告全身麻醉成本这一次要结局。3项试验(170名参与者)估计了熵组与对照组相比离开PACU的准备时间的MD(MD-5.94分钟,95%CI-16.08至4.20;证据质量低)。注意到存在异质性,这是由于一项研究中麻醉技术(丙泊酚全身麻醉)的差异。其余两项研究使用的是挥发性全身麻醉。这两项研究中离开PACU的准备时间的MD为-4.17分钟(95%CI-6.84至-1.51)。
作者结论
关于苏醒时间、术中知晓回忆以及吸入麻醉剂使用减少方面的证据质量中等。关于静脉麻醉剂(丙泊酚)使用减少以及离开PACU的准备时间方面的证据质量较低。由于数据有限,需要进一步纳入更多参与者的研究来确定熵监测的益处。需要进一步研究来评估熵监测对诸如短期和长期死亡率以及全身麻醉成本等重点问题的影响。
相似文献
Cochrane Database Syst Rev. 2016-3-14
Cochrane Database Syst Rev. 2018-8-21
Cochrane Database Syst Rev. 2020-10-19
Cochrane Database Syst Rev. 2018-3-2
Cochrane Database Syst Rev. 2016-10-18
Cochrane Database Syst Rev. 2021-8-16
Cochrane Database Syst Rev. 2018-6-4
Cochrane Database Syst Rev. 2016-11-15
Cochrane Database Syst Rev. 2021-4-19
引用本文的文献
Sensors (Basel). 2022-11-8
Pharmaceuticals (Basel). 2021-5-14
Ann Card Anaesth. 2020
本文引用的文献
Cochrane Database Syst Rev. 2014-6-17
Anesthesiology. 2013-4
J Cardiothorac Vasc Anesth. 2012-4-12
Curr Opin Anaesthesiol. 2011-12